Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

The Lancet publishes final 3-year data from landmark HORIZONS-AMI clinical trial

Data from the landmark HORIZONS-AMI clinical trial demonstrated that the administration of the anticoagulant medication bivalirudin enhanced survival compared to the use of heparin plus a glycoprotein (GP) IIb/IIIa inhibitor in heart attack patients undergoing angioplasty after 3 years. Use of a drug-eluting stent was also shown to be more effective than a bare-metal stent, with equivalent safety.

14 Jun 2011

Researchers discover genetic factor that can regulate obesity-induced inflammation

Researchers at Case Western Reserve University School of Medicine have discovered a genetic factor that can regulate obesity-induced inflammation that contributes to chronic health problems.

14 Jun 2011

Scientists discover new elements of blood clot-formation process

Scripps Research Institute scientists have discovered new elements of the blood clot-formation process. The findings could lead to better drugs for preventing heart attacks and other clot-related conditions.

14 Jun 2011

GE Healthcare announces results of Optison heart ultrasound contrast agent presented at ASE

Today, GE Healthcare Medical Diagnostics announced results of a study that evaluated the cardiopulmonary safety of Optison- (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent for use in improving suboptimal echocardiograms.

14 Jun 2011

Toshiba to highlight cardiac ultrasound applications at ASE annual meeting

Ultrasound is often used as a first-line diagnostic exam to quickly and safely diagnose a range of patient conditions. At this year's American Society of Echocardiography (ASE) annual meeting in Montreal, June 11-14, 2011, Toshiba America Medical Systems, Inc., will highlight cardiac and shared service ultrasound applications designed to improve cardiac ultrasound imaging.

13 Jun 2011

Quintiles, Kareus partner to advance KU-046 diabetes drug candidate into clinical trials

Kareus Therapeutics SA, the company focused on the development of novel therapeutics to address high unmet medical need, today announced a broad strategic alliance with Quintiles to progress the development of two of Kareus' pre-clinical programs through clinical trials.

13 Jun 2011

Mortality from all causes higher among hepatitis C-infected patients, study finds

Although liver-related mortality among those infected with hepatitis C is well-documented, little is known about deaths in these patients that are not related to liver problems. A new study published in Clinical Infectious Diseases and now available online sought to determine mortality from all causes, including liver- and non-liver related deaths among hepatitis C patients in the general U.S. population. The analysis found mortality from all causes to be higher in these patients.

10 Jun 2011

Larger trial study needed to decide fate of niacin

Niaspan is a cholesterol drug manufactured by Abbott Laboratories. Doctors have customarily prescribed Niacin to raise levels of HDL ("good" cholesterol) in patients taking a statin pill that is successfully lowering their LDL ("bad" cholesterol).

10 Jun 2011

Inspire's Stimulation Therapy for Apnea Reduction trial reaches milestones

Inspire Medical Systems, the leading developer of neurostimulation therapies for the treatment of obstructive sleep apnea (OSA), announced today The STAR trial, evaluating both the safety and effectiveness of Inspire Upper Airway Stimulation (UAS) therapy, is currently underway at 9 leading medical centers across the United States and at 4 sites in Europe.

10 Jun 2011

Researchers develop new imaging technology to detect cardiovascular disease

Researchers have developed a new type of imaging technology to diagnose cardiovascular disease and other disorders by measuring ultrasound signals from molecules exposed to a fast-pulsing laser.

10 Jun 2011

Exercise protects against silent stroke: Study

Strokes can cause brain damage by cutting off blood flow to the brain. But unlike major strokes, recognizable by symptoms such as weakness on one side of the body and trouble speaking, so-called silent strokes by definition go unnoticed. Symptoms can include subtle memory and mobility problems, as well as an increased risk for future strokes, according to the American Academy of Neurology. Silent strokes are also different from mini-strokes, which are noticeable but last only for minutes or hours.

9 Jun 2011

Being a young man is risky business for health

The Royal Australian College of General Practitioners (RACGP) is highlighting that young Australian men have higher rates of risky behaviours than young women and that this can put their health at immediate and long term risk. This warning comes as International Men’s Health Week takes place from 13 – 19 June 2011.

9 Jun 2011

New bariatric bed

Twenty-percent of the adult U.S. population is obese, including approximately five percent that are considered morbidly obese. The direct health issues, related complications and safety challenges affecting this population are far reaching and well documented. VitalGo, Inc., a provider of advanced technology-based solutions for medical staff safety, patient safety and home care, has announced the immediate availability of the new bariatric version of its Total Lift Bed™ (TLB) which addresses a wide variety of care, treatment and safety issues for patients weighing up to 1,000 lbs.

9 Jun 2011

National survey finds women more likely to see doctor on regular basis than men

A national survey found that women were three times more likely to see a doctor on a regular basis than men. Even though men on average die younger than women and have higher mortality rates for heart disease, cancer, stroke and AIDS, trying to get a man to a doctor can be harder than pulling teeth. So, why do men hate it so?.

9 Jun 2011

Thymosin beta 4 can transform adult epicardial stem cells into functional heart muscle

RegeneRx Biopharmaceuticals, Inc. has announced that thymosin beta 4 (Tβ4) can activate a unique subpopulation of resident adult epicardial stem cells such that they recapture embryonic potential, proliferate, migrate and differentiate into functional heart muscle (cardiomyocytes), according to a research paper published online today in Nature.

9 Jun 2011

More women than men are unnecessarily referred for nuclear stress tests

New research from cardiologists at Rhode Island and The Miriam hospitals suggests a possible gender disparity in how patients are referred for nuclear stress tests, an imaging technique that measures blood flow to the heart muscle both at rest and during periods of stress, such as exercise.

9 Jun 2011

Drug that makes the failing heart heal itself

Researchers have found that a drug can heal heart muscles in mice. Earlier it was considered that this damage to the heart is permanent but this new findings refutes earlier beliefs.

9 Jun 2011

Study determines surfactant protein-D as 'a good predictor' of cardiovascular disease

A blood protein known as surfactant protein-D (SP-D), which is mainly synthesised in the lungs, has been described as "a good predictor" of cardiovascular disease following a large study in North America.

8 Jun 2011

Einstein health expert plays an important role in development of U.S. News 'Best Diets' rankings

Yasmin Mossavar-Rahmani, Ph.D., R.D. of Albert Einstein College of Medicine of Yeshiva University played an important role in the development of the "Best Diets" rankings, which U.S. News released today.

8 Jun 2011

Cyterix raises $9.2M in Series A financing from The Column Group and SV Life Sciences

Cyterix Pharmaceutics, Inc. announced today that the company has raised $9.2 million in a Series A financing from The Column Group and SV Life Sciences. Cyterix is developing novel cancer therapeutics based on a prodrug approach that targets extra-hepatic cytochrome P450 enzymes that are over-expressed in many cancers to a high frequency, but not in normal tissues.

7 Jun 2011

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

The Lancet publishes final 3-year data from landmark HORIZONS-AMI clinical trial

Researchers discover genetic factor that can regulate obesity-induced inflammation

Scientists discover new elements of blood clot-formation process

GE Healthcare announces results of Optison heart ultrasound contrast agent presented at ASE

Toshiba to highlight cardiac ultrasound applications at ASE annual meeting

Quintiles, Kareus partner to advance KU-046 diabetes drug candidate into clinical trials

Mortality from all causes higher among hepatitis C-infected patients, study finds

Larger trial study needed to decide fate of niacin

Inspire's Stimulation Therapy for Apnea Reduction trial reaches milestones

Researchers develop new imaging technology to detect cardiovascular disease

Exercise protects against silent stroke: Study

Being a young man is risky business for health

New bariatric bed

National survey finds women more likely to see doctor on regular basis than men

Thymosin beta 4 can transform adult epicardial stem cells into functional heart muscle

More women than men are unnecessarily referred for nuclear stress tests

Drug that makes the failing heart heal itself

Study determines surfactant protein-D as 'a good predictor' of cardiovascular disease

Einstein health expert plays an important role in development of U.S. News 'Best Diets' rankings

Cyterix raises $9.2M in Series A financing from The Column Group and SV Life Sciences

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in